Diosmin
- diosmin
- 520-27-4
- Barosmin
- Diosimin
- Flebosten
- Create:2005-06-24
- Modify:2025-01-11
- Barosmin
- Buchu Resin
- Daflon
- Diosmin
- Resin, Buchu
- Venosmine
- diosmin
- 520-27-4
- Barosmin
- Diosimin
- Flebosten
- Venosmine
- Diosmil
- Diosmine
- Daflon
- Tovene
- Ven-Detrex
- Diovenor
- Buchu Resin
- Litosmil
- Veno-V
- flebosmil
- Diosminum
- Rioven
- Diosmetin 7-O-rutinoside
- Diosven
- Flebaven
- Flebavena
- Hemerven
- Insuven
- Varinon
- Dioven
- Diosmetin 7-rutinoside
- UNII-7QM776WJ5N
- Diosmin [INN]
- 7QM776WJ5N
- CCRIS 7915
- CHEBI:4631
- DTXSID4045892
- Diosmetin-7-O-rutinoside
- EINECS 208-289-7
- MFCD00009772
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
- NSC-758417
- 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside
- SE 4601
- DTXCID2025892
- 3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinoside
- Diosmin (INN)
- NSC 758417
- 3',5,7-trihydroxy-4'-methoxyflavone 7-rhamnoglucoside
- 3',5,7-Trihydroxy-4'-methoxyflavone-7-(6-O-(-deoxy-alpha-L-mannopyraonsyl)-beta-D-glucopyranoside
- 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
- 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid
- DIOSMIN (MART.)
- DIOSMIN [MART.]
- DIOSMIN (USP-RS)
- DIOSMIN [USP-RS]
- Diosmin, analytical standard
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
- 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glycopyranosyl)oxy)-4-chromenon
- DIOSMIN (EP MONOGRAPH)
- DIOSMIN [EP MONOGRAPH]
- 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid [IUPAC]
- Resin, Buchu
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 7-((6-O-(6-Deoxy-ga-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
- CAS-520-27-4
- Diosmin [INN:BAN]
- Diosmin [INN-Spanish]
- Diosmine [INN-French]
- Diosminum [INN-Latin]
- SR-01000799147
- Diosmina
- 3',5-Dihydroxy-4'-methoxy-4-oxo-4H-chromen-7-ylrutosid (IUPAC)
- NCGC00095022-01
- 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- 4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
- Diosmin (Standard)
- Daflon (TN)
- Diosmin (8)
- DIOSMIN [DSC]
- DIOSMIN [MI]
- DIOSMIN [WHO-DD]
- MLS001304032
- SCHEMBL120870
- CHEMBL231884
- HY-N0178R
- C05CA03
- BDBM153267
- GLXC-13353
- HMS2233P16
- HMS3713L08
- Tox21_111392
- s2292
- AKOS015969767
- Tox21_111392_1
- BCP9000612
- CCG-208570
- DB08995
- SMP1_000183
- NCGC00344564-01
- AS-13224
- BP-12422
- SMR000718616
- BCP0726000067
- NS00005135
- C10039
- D07858
- EN300-18388399
- 3',5,7-trihydroxy-4'-methoxy flavone-7-rutinoside
- Q2607865
- SR-01000799147-4
- SR-01000799147-5
- SR-01000799147-6
- BRD-K94436377-001-10-2
- BRD-K94436377-001-11-0
- Diosmin, European Pharmacopoeia (EP) Reference Standard
- Diosmin, United States Pharmacopeia (USP) Reference Standard
- Diosmin for system suitability, European Pharmacopoeia (EP) Reference Standard
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(O6-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)chromen-4-one
- 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
- 5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-7-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-({[(2R,3R,4R,5R,6S)-3,4,5-TRIHYDROXY-6-METHYLOXAN-2-YL]OXY}METHYL)OXAN-2-YL]OXY}-4H-CHROMEN-4-ONE
- 7-((6-O-(6-DEOXY-GA-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
Use (kg) in France (2004): 373544
Consumption (g per capita) in France (2004): 6.18
Calculated removal (%): 45.4
Not Classified
Reported as not meeting GHS hazard criteria by 89 of 98 companies (only 9.2% companies provided GHS information). For more detailed information, please visit ECHA C&L website.
Aggregated GHS information provided per 98 reports by companies from 2 notifications to the ECHA C&L Inventory.
Reported as not meeting GHS hazard criteria per 89 of 98 reports by companies. For more detailed information, please visit ECHA C&L website.
There is 1 notification provided by 9 of 98 reports by companies with hazard statement code(s).
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Status: Active Update: 13-11-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/21071
Status: Active Update: 04-03-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/29559
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=GZSOSUNBTXMUFQ-YFAPSIMESA-N
- BindingDBLICENSEAll data curated by BindingDB staff are provided under the Creative Commons Attribution 3.0 License (https://creativecommons.org/licenses/by/3.0/us/).https://www.bindingdb.org/rwd/bind/info.jsp5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-onehttps://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=153267
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloads
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_use
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/
- ChemIDplusChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- EPA DSSToxCompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeDiosmin (EC: 208-289-7)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/68422
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEBI
- LOTUS - the natural products occurrence databaseLICENSEThe code for LOTUS is released under the GNU General Public License v3.0.https://lotus.nprod.net/LOTUS Treehttps://lotus.naturalproducts.net/
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licence
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Therapeutic Target Database (TTD)
- DailyMed
- EPA Chemical and Products Database (CPDat)EPA CPDat Classificationhttps://www.epa.gov/chemical-research/chemical-and-products-database-cpdat
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/DIOSMINNORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- EU Clinical Trials Register
- Japan Chemical Substance Dictionary (Nikkaji)
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlPhytochemical compoundshttp://www.genome.jp/kegg-bin/get_htext?br08003.kegAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.keg
- LIPID MAPSLuteolin 4'-methyl ether 7-rutinosidehttps://lipidmaps.org/databases/lmsd/LMPK12110814Lipid Classificationhttps://www.lipidmaps.org/
- Natural Product Activity and Species Source (NPASS)
- Metabolomics WorkbenchDiosmetin 7-neohesperidosidehttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=23902
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NIST Mass Spectrometry Data CenterLICENSEData covered by the Standard Reference Data Act of 1968 as amended.https://www.nist.gov/srd/public-law
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html
- SpectraBaseDiosmetin-7-rutinosidehttps://spectrabase.com/spectrum/8tLNIfpHkJu3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinosidehttps://spectrabase.com/spectrum/APgQPnaJe4WHesperetin-7-O-B-rutinosidehttps://spectrabase.com/spectrum/1eXfhFZ7nhzDiosmetin-7-rutinosidehttps://spectrabase.com/spectrum/5DjxJxvQK0e3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinosidehttps://spectrabase.com/spectrum/HJKcPjjSRqd3',5,7-Trihydroxy-4'-methoxyflavone 7-rutinosidehttps://spectrabase.com/spectrum/6FB9VDspAew
- Springer Nature
- The Cambridge Structural Database
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/
- Wikidata
- WikipediaSodium stibogluconatehttps://en.wikipedia.org/wiki/Sodium_stibogluconate
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.html
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 388345505https://pubchem.ncbi.nlm.nih.gov/substance/388345505